 |
|
|
 |
|
Rationale:
- Complete resolution of PTSD symptoms may not be possible for patients with a chronic form of the disorder; however, substantial
improvement in role functioning at home, at work, and in interpersonal relationships should be expected.
|
|
Evidence:
- Outcome studies measuring symptom reduction and psychosocial functioning with treatment are encouraging, even with residual
symptoms (17).
|
|
Comments:
- One study uses the SF-36 as a general outcome measure of physical and psychological symptoms and level of functioning (44); however, there are no questionnaires that are specifically established for the purpose of following patients with PTSD.
|
| FAQs |
|
|
|
Jeffrey P. Staab, MD, MS, is a consultant for Eli Lilly, Forest Laboratories, received honorarium from Abbott Laboratories, received grants from GlaxoSmithKline,
Pfizer. Michael Roy, MD, editorial consultant, received honorarium from PFizer.
Darren B. Taichman, MD, PhD, Editor, PIER, has received grant support from Actelion Pharmaceuticals Ltd , and honoraria for
continuing medical education grand rounds and lectures given.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2010 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|
Posttraumatic Stress Disorder
> Follow-up
